DAFTAR PUSTAKA

1. Burnham, T.A. 2001. Drug Fact and Comparison, 55 th Ed, St Louis: A Wolters Kluwers Company. pp. 902-944

2. Kaplan H.I & Sadock BJ. 1993. Pocket Handbook of Emergency Psychiatric Medicine, William Wilkins

3. Kaplan H.I. & Sadock B.J. 1994. Synopsis Psychiatry, 7 edition

4. Kode - Kimble, M. A. and Young, L. Y., 2002. Applied Therapeutic : The Clinical Use Of Drugs, Vancouver : Applied Therapeutic, Inc, pp.75.1-75.12

5. Nolan, S, Scoggin, J.A. Serotonin Syndrom: Recognition and Management

6. Rundell, J.R., Wise, M.G. 2000. Consultation Psychiatry, 3rd Ed., Washington: American Psychiatric Press, pp. 61-79

7. Swanson JW, Swartz MS, Van Dorn RA, Elbogen EB, Wagner HR, Rosenheck RA, et al. A nation study of violent behavior in person with schizophrenia. Arch Gen Psychiatry. 2006;63:490-499.

8. Bannett PN, Brown MJ. Psychotropic. In: Clinical Pharmacology. 9th ed. London:Elsevier; 2003.

9. Arbuckle MR, Gameroff MJ, Marcus SC, West JC, Wilk J, Olfson M. Psychiatry opinion and antipsychotic selection in the management of schizophrenia. Psychiatric Service. 2008;59(5):561-565.

10. Perel JM, Jann MW. Antipsychotics. In: Burton ME, Schentag JJ, Shaw LM, Evans WE (eds). Applied Pharmacokinetiks & Pharmakodynamics. 3rd ed. Baltimore: Lippincott Williams & Wilkins; 2006.

11. Krakowski MI, Czobor P, Citrome L, Bark N, Cooper TB. Atypical antipsychotic agents in the treatment of violent patient with schizophrenia and schizoaffective disorder. Arch Gen Psychiatry. 2006;63:622-629.